Simcere Pharmaceutical Group Limited (HK:2096)
:2096
2096 Analyst Ratings
Strong Buy
3 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
2096 Stock 12 Month Forecast
Average Price Target
HK$18.67
▲(35.88% Upside)
| Highest Price TargetHK$21.32 | Average Price TargetHK$18.67 | Lowest Price TargetHK$17.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
UBS
HK$16.3
Buy
18.63%
Upside
Reiterated
09/29/25
Unknown Analyst
Morgan StanleyNot Ranked
Morgan Stanley
HK$12.3
Hold
-10.48%
Downside
Reiterated
08/22/25
Unknown Analyst
GF SecuritiesNot Ranked
GF Securities
HK$13.5
Buy
-1.75%
Downside
Reiterated
07/04/25
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
UBS
HK$16.3
Buy
18.63%
Upside
Reiterated
09/29/25
Unknown Analyst
Morgan StanleyNot Ranked
Morgan Stanley
HK$12.3
Hold
-10.48%
Downside
Reiterated
08/22/25
Unknown Analyst
GF SecuritiesNot Ranked
GF Securities
HK$13.5
Buy
-1.75%
Downside
Reiterated
07/04/25
Best Analysts Covering Simcere Pharmaceutical Group Limited
3 Months
xxx
Success Rate
0/1 ratings generated profit
Average Return
-7.10%
reiterated a xxx
rating 7 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 0.00% of your transactions generating a profit, with an average return of -7.10% per trade.
1 Year
2 Years
xxx
Success Rate
0/1 ratings generated profit
Average Return
-9.90%
reiterated a xxx
rating 7 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -9.90% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
2096 Analyst Recommendation Trends
Rating
Nov 25
Dec 25
Jan 26
Feb 26
Mar 26
Strong Buy
1
2
3
3
2
Buy
5
1
0
0
1
Hold
1
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
7
3
3
3
3
Each month's total comprises the sum of three months' worth of ratings.
2096 Financial Forecast
2096 Stock Forecast FAQ
What is HK:2096’s average 12-month price target, according to analysts?
Based on analyst ratings, Simcere Pharmaceutical Group Limited’s 12-month average price target is 18.67.
What is HK:2096’s upside potential, based on the analysts’ average price target?
Simcere Pharmaceutical Group Limited has 35.88% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Simcere Pharmaceutical Group Limited a Buy, Sell or Hold?
Simcere Pharmaceutical Group Limited has a consensus rating of Strong Buy, which is based on 3 buy ratings, 0 hold ratings and 0 sell ratings.
What is Simcere Pharmaceutical Group Limited’s share price target?
The average share price target for Simcere Pharmaceutical Group Limited is 18.67. This is based on 3 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is HK$21.32 ,and the lowest forecast is HK$17.00. The average share price target represents 35.88% Increase from the current price of HK$13.74.
The highest analyst share price target is HK$21.32 ,and the lowest forecast is HK$17.00. The average share price target represents 35.88% Increase from the current price of HK$13.74.
What do analysts say about Simcere Pharmaceutical Group Limited?
Simcere Pharmaceutical Group Limited’s analyst rating consensus is a Strong Buy. This is based on the ratings of 3 Wall Streets Analysts.
How can I buy shares of Simcere Pharmaceutical Group Limited?
To buy shares of HK:2096, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.